Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Care > Global Kidney Fibrosis Treatment Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Global Kidney Fibrosis Treatment Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Industry: Medical Care

Published: 2023-05-30

Pages: 88 Pages

Report ld: 1257419

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.

Kidney Fibrosis Treatment report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Kidney Fibrosis Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Chronic Kidney Diseases and Kidney Cancer Treatment are the major drivers for the industry.

Increasing prevalence of chronic diseases such as kidney disorders is expected to trigger the growth of this market over the forecast period. Changing life style coupled with changing food habits is the prime reason for rising base of kidney disease patients and is expected to boost the market for kidney fibrosis treatments. Furthermore, factors such as increasing global geriatric population base, rising disposable income of the patients and growing awareness about renal fibrosis treatment are vital  factor for growth of this market during the forecast period. Continuous innovation in technology has led to development of safe and effective therapies for the treatment of chronic kidney diseases is also pushing the growth of kidney fibrosis treatment market. 
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Kidney Fibrosis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Companies, Type, Application and Regions Listed in the Report:
By Company
    Merck and Co(US)
    Pfizer Inc(US)
    F. Hoffman-La Roche(Switzerland)
    InterMune Inc(US)
    Galectin Therapeutics(US)
    La Jolla Pharmaceutical Company(US)
    ProMetic Life-Sciences Inc(Canada)
    BioLine Rx(Israel)
    Genzyme Corporation(US)

Segment by Type
    Angiotensin Converting Enzyme (ACE) Inhibitors
    Pirfenidone
    Renin Inhibitors
    Angiotensin II Receptor Blockers (ARBs)
    Vasopeptidase Inhibitors

Segment by Application
    Chronic Kidney Diseases
    Kidney Cancer Treatment
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        
    Latin America
        Mexico
        Brazil
        
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Kidney Fibrosis Treatment market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, Kidney Fibrosis Treatment introduction, etc. Kidney Fibrosis Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: QYResearch’s Conclusions of Kidney Fibrosis Treatment market based on comprehensive survey.
Chapter 13: Methodology and Data Sources adopted by QYResearch.

undefined

Table of Contents

1 Market Overview of Kidney Fibrosis Treatment
    1.1 Kidney Fibrosis Treatment Market Overview
        1.1.1 Kidney Fibrosis Treatment Product Scope
        1.1.2 Kidney Fibrosis Treatment Market Status and Outlook
    1.2 Global Kidney Fibrosis Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
    1.3 Global Kidney Fibrosis Treatment Market Size by Region (2018-2029)
    1.4 Global Kidney Fibrosis Treatment Historic Market Size by Region (2018-2023)
    1.5 Global Kidney Fibrosis Treatment Market Size Forecast by Region (2024-2029)
    1.6 Key Regions, Kidney Fibrosis Treatment Market Size (2018-2029)
        1.6.1 North America Kidney Fibrosis Treatment Market Size (2018-2029)
        1.6.2 Europe Kidney Fibrosis Treatment Market Size (2018-2029)
        1.6.3 Asia-Pacific Kidney Fibrosis Treatment Market Size (2018-2029)
        1.6.4 Latin America Kidney Fibrosis Treatment Market Size (2018-2029)
        1.6.5 Middle East & Africa Kidney Fibrosis Treatment Market Size (2018-2029)

2 Kidney Fibrosis Treatment Market by Type
    2.1 Introduction
        2.1.1 Angiotensin Converting Enzyme (ACE) Inhibitors
        2.1.2 Pirfenidone
        2.1.3 Renin Inhibitors
        2.1.4 Angiotensin II Receptor Blockers (ARBs)
        2.1.5 Vasopeptidase Inhibitors
    2.2 Global Kidney Fibrosis Treatment Market Size by Type: 2018 VS 2022 VS 2029
        2.2.1 Global Kidney Fibrosis Treatment Historic Market Size by Type (2018-2023)
        2.2.2 Global Kidney Fibrosis Treatment Forecasted Market Size by Type (2024-2029)
    2.3 Key Regions Market Size by Type
        2.3.1 North America Kidney Fibrosis Treatment Revenue Breakdown by Type (2018-2029)
        2.3.2 Europe Kidney Fibrosis Treatment Revenue Breakdown by Type (2018-2029)
        2.3.3 Asia-Pacific Kidney Fibrosis Treatment Revenue Breakdown by Type (2018-2029)
        2.3.4 Latin America Kidney Fibrosis Treatment Revenue Breakdown by Type (2018-2029)
        2.3.5 Middle East and Africa Kidney Fibrosis Treatment Revenue Breakdown by Type (2018-2029)

3 Kidney Fibrosis Treatment Market Overview by Application
    3.1 Introduction
        3.1.1 Chronic Kidney Diseases
        3.1.2 Kidney Cancer Treatment
        3.1.3 Others
    3.2 Global Kidney Fibrosis Treatment Market Size by Application: 2018 VS 2022 VS 2029
        3.2.1 Global Kidney Fibrosis Treatment Historic Market Size by Application (2018-2023)
        3.2.2 Global Kidney Fibrosis Treatment Forecasted Market Size by Application (2024-2029)
    3.3 Key Regions Market Size by Application
        3.3.1 North America Kidney Fibrosis Treatment Revenue Breakdown by Application (2018-2029)
        3.3.2 Europe Kidney Fibrosis Treatment Revenue Breakdown by Application (2018-2029)
        3.3.3 Asia-Pacific Kidney Fibrosis Treatment Revenue Breakdown by Application (2018-2029)
        3.3.4 Latin America Kidney Fibrosis Treatment Revenue Breakdown by Application (2018-2029)
        3.3.5 Middle East and Africa Kidney Fibrosis Treatment Revenue Breakdown by Application (2018-2029)

4 Kidney Fibrosis Treatment Competition Analysis by Players
    4.1 Global Kidney Fibrosis Treatment Market Size by Players (2018-2023)
    4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Kidney Fibrosis Treatment as of 2022)
    4.3 Date of Key Players Enter into Kidney Fibrosis Treatment Market
    4.4 Global Top Players Kidney Fibrosis Treatment Headquarters and Area Served
    4.5 Key Players Kidney Fibrosis Treatment Product Solution and Service
    4.6 Competitive Status
        4.6.1 Kidney Fibrosis Treatment Market Concentration Rate
        4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles
    5.1 Merck and Co(US)
        5.1.1 Merck and Co(US) Profile
        5.1.2 Merck and Co(US) Main Business
        5.1.3 Merck and Co(US) Kidney Fibrosis Treatment Products, Services and Solutions
        5.1.4 Merck and Co(US) Kidney Fibrosis Treatment Revenue (US$ Million) & (2018-2023)
        5.1.5 Merck and Co(US) Recent Developments
    5.2 Pfizer Inc(US)
        5.2.1 Pfizer Inc(US) Profile
        5.2.2 Pfizer Inc(US) Main Business
        5.2.3 Pfizer Inc(US) Kidney Fibrosis Treatment Products, Services and Solutions
        5.2.4 Pfizer Inc(US) Kidney Fibrosis Treatment Revenue (US$ Million) & (2018-2023)
        5.2.5 Pfizer Inc(US) Recent Developments
    5.3 F. Hoffman-La Roche(Switzerland)
        5.3.1 F. Hoffman-La Roche(Switzerland) Profile
        5.3.2 F. Hoffman-La Roche(Switzerland) Main Business
        5.3.3 F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Products, Services and Solutions
        5.3.4 F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Revenue (US$ Million) & (2018-2023)
        5.3.5 InterMune Inc(US) Recent Developments
    5.4 InterMune Inc(US)
        5.4.1 InterMune Inc(US) Profile
        5.4.2 InterMune Inc(US) Main Business
        5.4.3 InterMune Inc(US) Kidney Fibrosis Treatment Products, Services and Solutions
        5.4.4 InterMune Inc(US) Kidney Fibrosis Treatment Revenue (US$ Million) & (2018-2023)
        5.4.5 InterMune Inc(US) Recent Developments
    5.5 Galectin Therapeutics(US)
        5.5.1 Galectin Therapeutics(US) Profile
        5.5.2 Galectin Therapeutics(US) Main Business
        5.5.3 Galectin Therapeutics(US) Kidney Fibrosis Treatment Products, Services and Solutions
        5.5.4 Galectin Therapeutics(US) Kidney Fibrosis Treatment Revenue (US$ Million) & (2018-2023)
        5.5.5 Galectin Therapeutics(US) Recent Developments
    5.6 La Jolla Pharmaceutical Company(US)
        5.6.1 La Jolla Pharmaceutical Company(US) Profile
        5.6.2 La Jolla Pharmaceutical Company(US) Main Business
        5.6.3 La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Products, Services and Solutions
        5.6.4 La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Revenue (US$ Million) & (2018-2023)
        5.6.5 La Jolla Pharmaceutical Company(US) Recent Developments
    5.7 ProMetic Life-Sciences Inc(Canada)
        5.7.1 ProMetic Life-Sciences Inc(Canada) Profile
        5.7.2 ProMetic Life-Sciences Inc(Canada) Main Business
        5.7.3 ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Products, Services and Solutions
        5.7.4 ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Revenue (US$ Million) & (2018-2023)
        5.7.5 ProMetic Life-Sciences Inc(Canada) Recent Developments
    5.8 BioLine Rx(Israel)
        5.8.1 BioLine Rx(Israel) Profile
        5.8.2 BioLine Rx(Israel) Main Business
        5.8.3 BioLine Rx(Israel) Kidney Fibrosis Treatment Products, Services and Solutions
        5.8.4 BioLine Rx(Israel) Kidney Fibrosis Treatment Revenue (US$ Million) & (2018-2023)
        5.8.5 BioLine Rx(Israel) Recent Developments
    5.9 Genzyme Corporation(US)
        5.9.1 Genzyme Corporation(US) Profile
        5.9.2 Genzyme Corporation(US) Main Business
        5.9.3 Genzyme Corporation(US) Kidney Fibrosis Treatment Products, Services and Solutions
        5.9.4 Genzyme Corporation(US) Kidney Fibrosis Treatment Revenue (US$ Million) & (2018-2023)
        5.9.5 Genzyme Corporation(US) Recent Developments

6 North America
    6.1 North America Kidney Fibrosis Treatment Market Size by Country (2018-2029)
    6.2 U.S.
    6.3 Canada

7 Europe
    7.1 Europe Kidney Fibrosis Treatment Market Size by Country (2018-2029)
    7.2 Germany
    7.3 France
    7.4 U.K.
    7.5 Italy
    7.6 Russia
    7.7 Nordic Countries
    7.8 Rest of Europe

8 Asia-Pacific
    8.1 Asia-Pacific Kidney Fibrosis Treatment Market Size by Region (2018-2029)
    8.2 China
    8.3 Japan
    8.4 South Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australia
    8.8 Rest of Asia-Pacific

9 Latin America
    9.1 Latin America Kidney Fibrosis Treatment Market Size by Country (2018-2029)
    9.2 Mexico
    9.3 Brazil
    9.4 Rest of Latin America

10 Middle East & Africa
    10.1 Middle East & Africa Kidney Fibrosis Treatment Market Size by Country (2018-2029)
    10.2 Turkey
    10.3 Saudi Arabia
    10.4 UAE
    10.5 Rest of Middle East & Africa

11 Kidney Fibrosis Treatment Market Dynamics
    11.1 Kidney Fibrosis Treatment Industry Trends
    11.2 Kidney Fibrosis Treatment Market Drivers
    11.3 Kidney Fibrosis Treatment Market Challenges
    11.4 Kidney Fibrosis Treatment Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Market Kidney Fibrosis Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Kidney Fibrosis Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Kidney Fibrosis Treatment Market Size Share by Region (2018-2023)
    Table 4. Global Kidney Fibrosis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Kidney Fibrosis Treatment Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Kidney Fibrosis Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Kidney Fibrosis Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Kidney Fibrosis Treatment Revenue Market Share by Type (2018-2023)
    Table 9. Global Kidney Fibrosis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Kidney Fibrosis Treatment Revenue Market Share by Type (2024-2029)
    Table 11. North America Kidney Fibrosis Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Kidney Fibrosis Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Kidney Fibrosis Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Kidney Fibrosis Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Kidney Fibrosis Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Kidney Fibrosis Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Kidney Fibrosis Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Kidney Fibrosis Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Kidney Fibrosis Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Kidney Fibrosis Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Kidney Fibrosis Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Kidney Fibrosis Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Kidney Fibrosis Treatment Revenue Market Share by Application (2018-2023)
    Table 24. Global Kidney Fibrosis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Kidney Fibrosis Treatment Revenue Market Share by Application (2024-2029)
    Table 26. North America Kidney Fibrosis Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Kidney Fibrosis Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Kidney Fibrosis Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Kidney Fibrosis Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Kidney Fibrosis Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Kidney Fibrosis Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Kidney Fibrosis Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Kidney Fibrosis Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Kidney Fibrosis Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Kidney Fibrosis Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Kidney Fibrosis Treatment Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Kidney Fibrosis Treatment Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Kidney Fibrosis Treatment as of 2022)
    Table 39. Date of Key Players Enter into Kidney Fibrosis Treatment Market
    Table 40. Global Kidney Fibrosis Treatment Key Players Headquarters and Area Served
    Table 41. Kidney Fibrosis Treatment Product Solution and Service
    Table 42. Global Kidney Fibrosis Treatment Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Merck and Co(US) Basic Information List
    Table 45. Merck and Co(US) Description and Business Overview
    Table 46. Merck and Co(US) Kidney Fibrosis Treatment Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of Merck and Co(US) (2018-2023)
    Table 48. Merck and Co(US) Recent Developments
    Table 49. Pfizer Inc(US) Basic Information List
    Table 50. Pfizer Inc(US) Description and Business Overview
    Table 51. Pfizer Inc(US) Kidney Fibrosis Treatment Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of Pfizer Inc(US) (2018-2023)
    Table 53. Pfizer Inc(US) Recent Developments
    Table 54. F. Hoffman-La Roche(Switzerland) Basic Information List
    Table 55. F. Hoffman-La Roche(Switzerland) Description and Business Overview
    Table 56. F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of F. Hoffman-La Roche(Switzerland) (2018-2023)
    Table 58. F. Hoffman-La Roche(Switzerland) Recent Developments
    Table 59. InterMune Inc(US) Basic Information List
    Table 60. InterMune Inc(US) Description and Business Overview
    Table 61. InterMune Inc(US) Kidney Fibrosis Treatment Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of InterMune Inc(US) (2018-2023)
    Table 63. InterMune Inc(US) Recent Developments
    Table 64. Galectin Therapeutics(US) Basic Information List
    Table 65. Galectin Therapeutics(US) Description and Business Overview
    Table 66. Galectin Therapeutics(US) Kidney Fibrosis Treatment Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of Galectin Therapeutics(US) (2018-2023)
    Table 68. Galectin Therapeutics(US) Recent Developments
    Table 69. La Jolla Pharmaceutical Company(US) Basic Information List
    Table 70. La Jolla Pharmaceutical Company(US) Description and Business Overview
    Table 71. La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of La Jolla Pharmaceutical Company(US) (2018-2023)
    Table 73. La Jolla Pharmaceutical Company(US) Recent Developments
    Table 74. ProMetic Life-Sciences Inc(Canada) Basic Information List
    Table 75. ProMetic Life-Sciences Inc(Canada) Description and Business Overview
    Table 76. ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of ProMetic Life-Sciences Inc(Canada) (2018-2023)
    Table 78. ProMetic Life-Sciences Inc(Canada) Recent Developments
    Table 79. BioLine Rx(Israel) Basic Information List
    Table 80. BioLine Rx(Israel) Description and Business Overview
    Table 81. BioLine Rx(Israel) Kidney Fibrosis Treatment Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of BioLine Rx(Israel) (2018-2023)
    Table 83. BioLine Rx(Israel) Recent Developments
    Table 84. Genzyme Corporation(US) Basic Information List
    Table 85. Genzyme Corporation(US) Description and Business Overview
    Table 86. Genzyme Corporation(US) Kidney Fibrosis Treatment Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of Genzyme Corporation(US) (2018-2023)
    Table 88. Genzyme Corporation(US) Recent Developments
    Table 89. North America Kidney Fibrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 90. North America Kidney Fibrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 91. Europe Kidney Fibrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 92. Europe Kidney Fibrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 93. Asia-Pacific Kidney Fibrosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 94. Asia-Pacific Kidney Fibrosis Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 95. Asia-Pacific Kidney Fibrosis Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 96. Asia-Pacific Kidney Fibrosis Treatment Market Share by Region (2018-2023)
    Table 97. Asia-Pacific Kidney Fibrosis Treatment Market Share by Region (2024-2029)
    Table 98. Latin America Kidney Fibrosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 99. Latin America Kidney Fibrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 100. Latin America Kidney Fibrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 101. Middle East & Africa Kidney Fibrosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 102. Middle East & Africa Kidney Fibrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 103. Middle East & Africa Kidney Fibrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 104. Kidney Fibrosis Treatment Market Trends
    Table 105. Kidney Fibrosis Treatment Market Drivers
    Table 106. Kidney Fibrosis Treatment Market Challenges
    Table 107. Kidney Fibrosis Treatment Market Restraints
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Kidney Fibrosis Treatment Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Kidney Fibrosis Treatment Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Kidney Fibrosis Treatment Market Share by Regions: 2022 VS 2029
    Figure 4. Global Kidney Fibrosis Treatment Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Kidney Fibrosis Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Kidney Fibrosis Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Kidney Fibrosis Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Kidney Fibrosis Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Kidney Fibrosis Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Angiotensin Converting Enzyme (ACE) Inhibitors
    Figure 11. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Pirfenidone
    Figure 13. Global Pirfenidone Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of Renin Inhibitors
    Figure 15. Global Renin Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Product Picture of Angiotensin II Receptor Blockers (ARBs)
    Figure 17. Global Angiotensin II Receptor Blockers (ARBs) Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 18. Product Picture of Vasopeptidase Inhibitors
    Figure 19. Global Vasopeptidase Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 20. Global Kidney Fibrosis Treatment Market Size Share by Type:  2022 & 2029
    Figure 21. North America Kidney Fibrosis Treatment Revenue Market Share by Type (2018-2029)
    Figure 22. Europe Kidney Fibrosis Treatment Revenue Market Share by Type (2018-2029)
    Figure 23. Asia-Pacific Kidney Fibrosis Treatment Revenue Market Share by Type (2018-2029)
    Figure 24. Latin America Kidney Fibrosis Treatment Revenue Market Share by Type (2018-2029)
    Figure 25. Middle East and Africa Kidney Fibrosis Treatment Revenue Market Share by Type (2018-2029)
    Figure 26. Chronic Kidney Diseases Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 27. Kidney Cancer Treatment Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 28. Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 29. Global Kidney Fibrosis Treatment Market Size Share by Application: 2022 & 2029
    Figure 30. North America Kidney Fibrosis Treatment Revenue Market Share by Application (2018-2029)
    Figure 31. Europe Kidney Fibrosis Treatment Revenue Market Share by Application (2018-2029)
    Figure 32. Asia-Pacific Kidney Fibrosis Treatment Revenue Market Share by Application (2018-2029)
    Figure 33. Latin America Kidney Fibrosis Treatment Revenue Market Share by Application (2018-2029)
    Figure 34. Middle East and Africa Kidney Fibrosis Treatment Revenue Market Share by Application (2018-2029)
    Figure 35. Kidney Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 36. Global Top 5 and Top 10 Players Kidney Fibrosis Treatment Market Share in 2022
    Figure 37. North America Kidney Fibrosis Treatment Market Share by Country (2018-2029)
    Figure 38. U.S. Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 39. Canada Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 40. Germany Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 41. France Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 42. U.K. Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 43. Italy Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 44. Russia Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 45. Nordic Countries Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 46. Asia-Pacific Kidney Fibrosis Treatment Market Share by Region (2018-2029)
    Figure 47. China Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 48. Japan Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 49. South Korea Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 50. Southeast Asia Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 51. India Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 52. Australia Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 53. Latin America Kidney Fibrosis Treatment Market Share by Country (2018-2029)
    Figure 54. Mexico Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 55. Brazil Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 56. Middle East & Africa Kidney Fibrosis Treatment Market Share by Country (2018-2029)
    Figure 57. Turkey Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 58. Saudi Arabia Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 59. UAE Kidney Fibrosis Treatment Market Size (2018-2029) & (US$ Million)
    Figure 60. Bottom-up and Top-down Approaches for This Report

Description

Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.

Kidney Fibrosis Treatment report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Kidney Fibrosis Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Chronic Kidney Diseases and Kidney Cancer Treatment are the major drivers for the industry.

Increasing prevalence of chronic diseases such as kidney disorders is expected to trigger the growth of this market over the forecast period. Changing life style coupled with changing food habits is the prime reason for rising base of kidney disease patients and is expected to boost the market for kidney fibrosis treatments. Furthermore, factors such as increasing global geriatric population base, rising disposable income of the patients and growing awareness about renal fibrosis treatment are vital  factor for growth of this market during the forecast period. Continuous innovation in technology has led to development of safe and effective therapies for the treatment of chronic kidney diseases is also pushing the growth of kidney fibrosis treatment market. 
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Kidney Fibrosis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Companies, Type, Application and Regions Listed in the Report:
By Company
    Merck and Co(US)
    Pfizer Inc(US)
    F. Hoffman-La Roche(Switzerland)
    InterMune Inc(US)
    Galectin Therapeutics(US)
    La Jolla Pharmaceutical Company(US)
    ProMetic Life-Sciences Inc(Canada)
    BioLine Rx(Israel)
    Genzyme Corporation(US)

Segment by Type
    Angiotensin Converting Enzyme (ACE) Inhibitors
    Pirfenidone
    Renin Inhibitors
    Angiotensin II Receptor Blockers (ARBs)
    Vasopeptidase Inhibitors

Segment by Application
    Chronic Kidney Diseases
    Kidney Cancer Treatment
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        
    Latin America
        Mexico
        Brazil
        
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Kidney Fibrosis Treatment market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, Kidney Fibrosis Treatment introduction, etc. Kidney Fibrosis Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: QYResearch’s Conclusions of Kidney Fibrosis Treatment market based on comprehensive survey.
Chapter 13: Methodology and Data Sources adopted by QYResearch.

undefined

Related Reports

Global Kidney Fibrosis Treatment Market Research Report 2023
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2023-06-11
Pages: 85
USD 2900.00
(Single User License)
Global Kidney Fibrosis Treatment Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2023-05-30
Pages: 102
USD 5600.00
(Single User License)
Global Kidney Fibrosis Treatment Market Insights, Forecast to 2029
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2023-05-31
Pages: 91
USD 4900.00
(Single User License)
Global Kidney Fibrosis Treatment Market Research Report 2024
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2024-01-04
Pages: 78
USD 2900.00
(Single User License)
Kidney Fibrosis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2024-01-24
Pages: 92
USD 3950.00
(Single User License)
Global Kidney Fibrosis Treatment Market Insights, Forecast to 2030
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2024-04-28
Pages: 88
USD 4900.00
(Single User License)
Global Kidney Fibrosis Treatment Market Research Report 2025
The global market for Kidney Fibrosis Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-27
Pages: 71
USD 2900.00
(Single User License)
Kidney Fibrosis Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Kidney Fibrosis Treatment was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 89
USD 3950.00
(Single User License)